Fig. 5

Kaplan–Meier curves for the overall survival (OS) of patients with triple-negative breast cancer. a OS curves in cancer-associated fibroblast (CAF) PD-L1-positive (red line) and -negative (blue line) patients evaluated using the 73–10 assay. b OS curves in CAF PD-L1-positive (red line) and -negative (blue line) patients evaluated using the SP142 assay. c OS curves in CAF PD-L1-positive (red line) and -negative (blue line) patients evaluated using the E1L3N assay